Leave Your Message
Nitroxoline: Top China Suppliers & Factory for Effective Treatment of Urinary Tract Infections
Hot Products

Nitroxoline: Top China Suppliers & Factory for Effective Treatment of Urinary Tract Infections

Nitroxoline, also known as 5-nitroquinolin-8-ol, is a powerful urinary antibacterial agent effective against various susceptible gram-positive and gram-negative bacteria commonly associated with urinary tract infections. As a prominent choice among suppliers in China, our nitroxoline is manufactured in state-of-the-art factories that adhere to strict quality standards. This ensures that you receive a reliable product ideal for treating urinary infections while meeting the demands of healthcare professionals and patients alike. Choose our high-quality nitroxoline for effective treatment options sourced directly from reputable suppliers in China

    Product parameters

    Product Name Nitroxoline
    CAS NO 4008-48-4
    Structure Nitroquinoline.jpg
    Molecular formula C9H6N2O3
    Purity Over 99.5%
    Other product names 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, 5-nitroquinolin-8-ol
    Molecular weight 190.16

    In vitro activity

    Using spectrophotometric fluorescence assay, Nitroxoline can significantly reduce the degradation of extracellular DQ collagen IV in all tested cancer cell lines. Nitroxoline can significantly reduce real-time monitoring of tumor cell invasion and decrease the invasive growth of multicellular tumor spheroids, which can be used as a three-dimensional vitreous model of tumor invasion. In vitro angiogenesis experiments, Nitroxoline can significantly reduce the formation of endothelial tubes.

    In vitro activity

    Nitroxoline significantly inhibited tumor growth, angiogenesis and metastasis in LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.

    Kinase experiment

    In Vitro Kinase Assays : The potency of SP600125 towards kinases, including MPS1, JNK, and Aurora kinase A, is determined based on the specific measurement of radioactive phosphotransfer to the substrate. For each enzyme, the absolute Km values for ATP and the specific substrate are initially determined and each assay is then run at optimized [ATP] (2·αKm) and [substrate] (5·Km) concentrations. MPS1 activity is measured using 5 nM of MPS1 recombinant protein in 50 mM HEPES pH 7.5, 2.5 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 3 μM NaVO3, 2 mM β-glycerophosphate, 0.2 mg/mL BSA, 200 μM P38-βtide substrate-peptide (KRQADEEMTGYVATRWYRAE), and 8 μM ATP with 1.5 nM 33P-γ-ATP. Ten serial 1:3 dilutions (from 30 μM to 1.5 nM) of SP600125 are tested and IC50 determined.

    Cell experiment

    Cell suspension are seeded in the wells of an E-plate 16 according to the manufacturer's instructions. After seeding, the CI is monitored every 15 min. After ∼10 h (MCF-10A neoT and MMTV-PyMT), 14 h (U-87 MG) or 24 h (LPB), when the cells are in their log phase of growth, 50 μl of the compound or 0.1% DMSO is added, and the experiment allowed to run for 72 h. Once every 24 h the medium is replaced with fresh medium containing the inhibitor or suitable control to prevent cell death due to medium depletion. Compounds and their concentrations are: nitroxoline (5 μM) and CA-074 (5 μM) for all cell lines other than MCF-10A neoT cell line, where nitroxoline was used at 2.5 μM. All measurements were performed in quadruplicate. (Only for Reference)
    Frequently Asked Questions (FAQ)

    What is the CAS number and molecular formula of Nitroxoline?

    Nitroxoline has the CAS number 4008-48-4 and the molecular formula C9H6N2O3.

    What is the purity level of Nitroxoline?

    The purity level of Nitroxoline is over 99.5%.

    What are the other names for Nitroxoline?

    Nitroxoline is also known as 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, and 5-nitroquinolin-8-ol.

    How does Nitroxoline affect tumor cells and angiogenesis in vitro?

    In vitro, Nitroxoline significantly reduces the degradation of extracellular DQ collagen IV in cancer cell lines, decreases tumor cell invasion, limits the growth of multicellular tumor spheroids, and reduces endothelial tube formation during angiogenesis.

    Does Nitroxoline show efficacy in in vivo tumor models?

    Yes, Nitroxoline has been shown to significantly inhibit tumor growth, angiogenesis, and metastasis in both LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.

    What concentration of Nitroxoline is recommended for cell experiments?

    A concentration of 5 μM of Nitroxoline is used for most cell lines (such as U-87 MG, LPB, and MMTV-PyMT), except for the MCF-10A neoT cell line, where it is used at 2.5 μM.